Presbyopia Drops: A Foundation for Future Care - Summary - MDSpire

Presbyopia Drops: A Foundation for Future Care

Presbyopia drops are more than just a new tool—they’re a strategic entry point into the lifelong care pathway for patients with presbyopia.

  • By

  • Mitchell A. Jackson, MD

  • Melissa Bollinger, OD, FAAO

  • November 1, 2025

  • 7 min

Share

Objective:

To explore the role of presbyopia drops as a strategic entry point into lifelong care for patients experiencing age-related vision changes, emphasizing their potential to foster ongoing engagement.

Key Findings:
  • Presbyopia drops serve as a gateway to long-term eye care.
  • Early positive experiences with drops influence future care decisions, such as opting for premium IOLs.
  • Customizability of drops empowers patients and enhances engagement.
Interpretation:

Presbyopia drops not only address immediate vision concerns but also foster a proactive approach to ongoing eye health, encouraging patients to remain engaged in their care and understand the journey of presbyopia.

Limitations:
  • Residual skepticism from patients and providers regarding the efficacy of presbyopia drops.
  • Need for patient education on the adaptation process and temporary nature of the solution, along with strategies to build trust.
Conclusion:

Presbyopia drops are a vital tool for initiating a lifelong care pathway, enhancing patient satisfaction and investment in long-term eye health.

Original Source(s)

Presbyopia Drops: A Foundation for Future Care

  • by Mitchell A. Jackson, MD, Melissa Bollinger, OD, FAAO

  • November 1, 2025

Related Content

FDA Approves TECNIS PureSee IOL for Cataract Surgery

First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL

  • March 23, 2026

  • 2 min
Dual-Mechanism Drop Wins FDA Approval

FDA approves Tenpoint Therapeutics’ YUVEZZI eye drop for presbyopia

  • February 2, 2026

  • 2 min
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

Deseyne delivers smooth, continuous focus across near, intermediate, and distance vision, which is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner.